SDSandoz Group AG SDZNY · OTC
$92.17 -0.88% (-$0.82)
- Market cap
- $40.2B
- Enterprise value
- $44.2B
- P/E
- 43.8x
- Forward P/E
- 22.2x
- PEG
- 0.0x
- P/S
- 3.6x
- P/FCF
- 49.7x
- EV/EBITDA
- 25.8x
- ROIC
- 8.2%
- Gross margin
- 47.0%
- Net margin
- 8.2%
- Dividend yield
- 1.10%
- Payout ratio
- 48.1%
- Net debt/EBITDA
- 2.3x
- Beta
- 0.49
- Free float
- 96.2%
About the company
Sandoz Group AG is a Swiss pharmaceutical company specializing in the production of generic drugs and biosimilar products. Founded in 1886, it is now a part of the Novartis group. Sandoz is one of the global leaders in generics, producing drugs that are identical to original products but more affordable. The company focuses on areas such as oncology, cardiovascular diseases, neurology, and infections. Sandoz is known for its innovation in biotechnology, providing high-quality, safe, and affordable treatments to patients worldwide.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard Saynor
Employees
23,000
Headquarters
Basel
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number